Fresh news on health and wellness in Saint Vincent and the Grenadines

Provided by AGP

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

Press releases published on May 13, 2026

Aware Announces Successful Independent Evaluation of Intelligent Liveness Aligned with CEN/TS 18099
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Disease
Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026
SS Innovations Reports First Quarter 2026 Financial Results
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01
Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
NHA’s 2026 Industry Outlook Highlights Growing Need for Allied Health Professionals and the Rising Value of Certification
Lite Strategy Reports Fiscal 2026 Third Quarter Results
Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Candel Therapeutics to Present at Upcoming Investor Conferences
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
Valitor to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

Share us

on your social networks:

Sign up for:

St. Vincent & Grenadines Health Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.